Search alternatives:
mean decrease » a decrease (Expand Search)
can decrease » a decrease (Expand Search), a decreased (Expand Search)
nn decrease » a decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
12 nn » 12 nm (Expand Search)
mean decrease » a decrease (Expand Search)
can decrease » a decrease (Expand Search), a decreased (Expand Search)
nn decrease » a decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
12 nn » 12 nm (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Data_Sheet_1_Perceptual Priming Can Increase or Decrease With Aging.PDF
Published 2020“…Thus, perceptual priming can increase or decrease with age or cognitive impairment, but these changes do not covary with explicit memory.…”
-
9
-
10
SU9518 decreases cell proliferation and restore normal remodeling in eNOS (−/−) mice.
Published 2012“…(B) Representative hematoxylin and eosin stained LC cross sections of vehicle or SU9518 treated mice. Inward remodeling can be seen in SU9518 treated LC. Scale bar represents 100 µm. …”
-
11
-
12
Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad)
Published 2017“…The catch of tsetse from 44 sentinel biconical traps declined after target deployment with only five tsetse being caught in nine surveys giving a mean catch of 0.005 tsetse/trap/day. Modelling indicates that 70.4% (95% CI: 51–95%) of the reduction in reported cases between 2013 and 2015 can be attributed to vector control with the rest due to medical intervention. …”
-
13
-
14
-
15
-
16
-
17
-
18
Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches).
Published 2015Subjects: -
19
Baseline characteristics of study participants.
Published 2025“…For each age group, the mumps IgG seroprevalence rates were 74.40%, 89.02%, 85.58%, 68.60%, 69.28%, 78.42%, and 80.63% for those <8 months, 8 months-2 years, 3–5 years, 6–17 years, 18–39 years, 40–59 years, and>=60 years, respectively. In terms of the percentage decreases in anti-mumps antibody titers, in the population receiving the 1-dose vaccine, there was a mean decrease of 2.06% per year. …”
-
20
The numerical data used in this study.
Published 2025“…For each age group, the mumps IgG seroprevalence rates were 74.40%, 89.02%, 85.58%, 68.60%, 69.28%, 78.42%, and 80.63% for those <8 months, 8 months-2 years, 3–5 years, 6–17 years, 18–39 years, 40–59 years, and>=60 years, respectively. In terms of the percentage decreases in anti-mumps antibody titers, in the population receiving the 1-dose vaccine, there was a mean decrease of 2.06% per year. …”